指南与共识免疫规划卫生政策与健康促进

发热性疾病期间接种疫苗,我们了解什么?文献与国际推荐的系统-叙述混合综述

Vaccination during febrile illness, what do we know? A systematic-narrative hybrid review of the literature and international recommendations.
指南 / 共识 · Vaccine · 2024-10-24

该综述采用系统-叙述混合方法检索PubMed和Cochrane图书馆至2024年3月,纳入6项儿童发热性疾病期间接种疫苗的免疫原性和安全性研究及9项医患态度研究,并回顾国际推荐。儿童研究均显示发热期间接种与对照在血清转化率、保护性抗体水平或不良事件上无显著差异;各国推荐分为三类;推迟接种与低疫苗覆盖率相关。

要点

  • 儿童发热期间接种与对照在血清转化率、保护性抗体水平或不良事件上无显著差异。
  • 国际推荐分三类:不考虑体温推荐接种、体温限值内推荐接种、推荐不明确。
  • 推迟接种与低疫苗覆盖率相关,可视为错失接种机会。

核心结论

  • 儿童发热期间接种的免疫原性和安全性研究结果令人放心,但仅限儿童。
  • 尽管证据相同,各国推荐不同,可能解释医患对发热期间接种的犹豫。
  • 推迟接种与低疫苗覆盖率相关,可视为错失接种机会。
  • 作者认为似需更高水平证据才能得出确定结论。

研究设计与样本

  • 系统-叙述混合综述,检索PubMed和Cochrane图书馆数据库至2024年3月。
  • 纳入标准为涉及儿童或成人发热性疾病期间接种疫苗的研究,排除接种后发热或动物实验研究。
  • 同时回顾国际推荐,纳入文献由作者全面审查合格性。
  • 共纳入6项儿童免疫原性和安全性研究及9项医患态度文章。

主要发现

  • 6项儿童研究均显示发热期间接种与对照在血清转化率、保护性抗体水平或不良事件上无显著差异。
  • 9项医患态度文章显示发热时接种常被推迟,主要为避免潜在并发症。
  • 国际推荐分为三类:不考虑体温推荐接种、体温限值内推荐接种、推荐不明确。

关键数值与推荐

  • 国际推荐分类:推荐不考虑体温接种、推荐体温限值内接种、推荐不明确。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 免疫原性和安全性研究仅在儿童中进行。
  • 作者认为似需更高水平证据才能得出确定结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Vaccination during febrile illness (FI) is often regarded as a contraindication, leading to its postponement in most cases. Considering the doubts about the immunogenicity, efficacy and safety of the procedure among physicians and patients, we sought in this review to assess the data in the literature and international recommendations in terms of vaccination during FI. METHODS: This review was conducted according to the methodological structure for systematic-narrative hybrid reviews, using PubMed and Cochrane library databases until March 2024. Inclusion criteria were studies dealing with vaccination during FI in children or adults, and exclusion criteria were studies related to post-vaccination fever or animal experiments. A review of international recommendations was also carried out. Articles included were fully examined by the authors for eligibility. RESULTS: Our literature search enabled us to identify six studies about the immunogenicity and safety of vaccination during FI in children. All have shown no significant differences in seroconversion rates, protective antibody levels or adverse events between children vaccinated during FI and controls. Nine articles on physicians and patients' attitudes regarding immunization during FI were also included in this review. Vaccination was frequently postponed in cases of fever, primarily to avoid potential complications. Review of international recommendations allowed us to classify countries into three categories: those recommending vaccination regardless of the body temperature, those recommending vaccination within a temperature limit, and those with unclear recommendations. DISCUSSION: The immunogenicity and safety studies were only conducted in children, yet results were reassuring. Despite using the same evidence, recommendations differed from country to another. This situation may explain the reluctance of physicians and patients to embrace this practice. Postponing vaccination is however associated with low vaccine coverage and could be considered a missed opportunity to vaccinate. A higher level of evidence seems needed for a firm conclusion.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Essalim S, Tachet C, Demingo S, et al. Vaccination during febrile illness, what do we know? A systematic-narrative hybrid review of the literature and international recommendations. Vaccine. 2024. PMID: 39454291. doi:10.1016/j.vaccine.2024.126473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。